Atrial fibrillation: diagnosis and management

Supporting evidence

• Full guidance

• Full guideline – June 2014

• Full guideline (PDF 3.59 MB)

  Published:

  27 April 2021

• Appendices A to R (PDF 10.16 MB)

  Published:

  27 April 2021

• Evidence review

• Evidence reviews – April 2021

• A: Effectiveness of tests for detection (PDF 2.43 MB)

  Published:

  27 April 2021

• B: Accuracy of tests for detection (PDF 5.25 MB)

  Published:

  27 April 2021

• C and D: Tools to predict stroke in people with atrial fibrillation (PDF 6.6 MB)

  Published:

  27 April 2021

• E and F: Risk stratification tools for predicting bleeding in people with atrial fibrillation (PDF 5.05 MB)

  Published:

  27 April 2021

• G1: Anticoagulant therapy for stroke prevention in people with atrial fibrillation (PDF 2.9 MB)

  Published:

  27 April 2021

• G2: Anticoagulant therapy: health economics analysis (PDF 7.81 MB)

  Published:

  27 April 2021

• H: Discontinuing anticoagulation in people whose atrial fibrillation has resolved (PDF 781 KB)

  Published:

  27 April 2021

• I: Non-ablative rate control therapies (PDF 1.4 MB)

  Published:

  27 April 2021

• J1: Ablation (PDF 3.34 MB)

  Published:

  27 April 2021

• J2: Ablation: network meta-analysis (PDF 952 KB)

  Published:

  27 April 2021

• J3: Ablation: cost-effectiveness analysis (PDF 2.01 MB)

  Published:

  27 April 2021

• K: Antiarrhythmic drugs after ablation (PDF 1.02 MB)

  Published:

  27 April 2021

• L: Treatment strategies for atrial fibrillation after cardiothoracic surgery (PDF 1.71 MB)

  Published:

  27 April 2021

• M: Statins for preventing atrial fibrillation after cardiothoracic surgery (PDF 1.17 MB)

  Published:

  27 April 2021

• Other supporting evidence

• Methods (PDF 1.33 MB)

  Published:

  27 April 2021